Medicinal & Aromatic Plants

Medicinal & Aromatic Plants
Open Access

ISSN: 2167-0412

+44 1300 500008

Research Article - (2016) Volume 5, Issue 3

Isolation, Characterisation and Antifungal Activity of β-Lapachone from Tecomaria capensis (Thunb.) Spach Leaves

Karthikeyan R1*, Sai Koushik O1 and Kumar PV2
1Vignan Pharmacy College, Vadlamudi, Guntur-522 213, Andhra Pradesh, India
2Faulty of Pharmaceutical Sciences, UCSI University, Kualalampur, Malaysia
*Corresponding Author: Karthikeyan R, Vignan Pharmacy College, Vadlamudi, Guntur-522 213, Andhra Pradesh, India, Tel: 91-9966847127 Email:

Abstract

β-Lapachone (3, 4-dihydro-2,2-dimethyl-2H-naphthol [1,2-b] pyran-5,6-dione), was originally isolated from the lapacho tree (Tabebuia avellanedae) of South America. It is a lipophilic ortho-naphthoquinone. β-Lapachone has antimicrobial, antifungal, antiviral antitumor and anti-trypanosomal activities. In a number of tumors (e.g., breast, colon, lung, and pancreatic cancers) with high NAD (P) H expression levels of: quinone oxidoreductase (NQO1), β-lapachone activates a novel apoptotic response. β-Lapachoneis a major constituent of the species Tecomaria capensis (Thunb.) Spach. On silica gel GF254 TLC plates and the chromate plate analytical thin layer chromatography was accomplished. It was developed withToluene: Ethyl acetate (7:3 v/v) as mobile phase. In this study isolation of β-Lapachone was achieved by preparative TLC. The compound thus isolated was characterised by Mass, H1 NMR and FT-IR spectral analysis. Mass spectral data shows molecular ion peak of m/z=242. Antifungal activity was measured against Candida albicans and Aspergillus nigrus fromethyl acetate extracts of selected species.

Keywords: Tecomaria capensis (Thunb.) Spach leaves; β-Lapachone; FT-IR; H1NMR; MASS; Antifungal activity

Introduction

Naphthoquinones display very substantial pharmacological properties; like antipyretic, antibacterial, antifungal, insecticidal, antiinflammatory and antiviral properties. Cardiovascular and reproductive system related pharmacological effects have been demonstrated too [1]. β-Lapachone (3,4-dihydro-2,2-dimethyl-2H- naphthol[1,2-b] pyran- 5,6-dione), a lipophilic ortho-naphthoquinone, was originally isolated from the lapacho tree (Tabebuia avellanedae) of South America [2-5]. Beta-lapachone can be easily synthesized by chemical transformation of lapachol, also extracted from the bark of plants of the Bignoniaceae family or from lomatiol, isolated from seeds of lomatia [6]. it is reported to present a significant anti-neoplastic activity against human cancer cell lines originating from leukemia [7], prostate [8], malignant glioma [9], hepatoma [10], colon [11,12], breast [13], ovarian [14], pancreatic [15,16] tumors, at concentrations in the range of 1-10 μM (IC50). Other studies have shown that in combination with taxol, beta-lapachone is an effective agent against human ovarian and prostate xenografts in mice. This naphthoquinone was reported to have, anti-Trypanosoma properties [17-19]. Previous studies showing antifungal activity of lapachol and beta-lapachone against C. neoformans are to some extent contradictory because of the different experimental protocols used [20]. Nevertheless, these data indicate that new studies are necessary before proposing antifungal tests on humans. This study was aimed to isolate, characterize and evaluation of antifungal activity of β-lapachone against Candida albicans and Aspergillus nigrus from ethyl acetate extracts of the species. Development of suitable extraction and isolation procedure which aids to get the purified material. Further the study also deals with characterisation of β-lapachone in the sample extract by Mass and H1 NMR and FT-IR spectral analysis for structure identification.

Materials and Methods

Instruments

Double beam UV-Visible Spectrophotometer (Systronics model 2203) with matched cuvettes was used in this study. In addition, an electronic balance (Shimadzu TX223L), digital pH meter (Systronics model 802), and an ultrasonic bath sonicator (spectra lab, model UCB 40).

Chemicals and reagents

Methanol, Ethanol and Sulphuric acid was purchased from Merck Pvt. Ltd. Mumbai, India. And chloroform was procured from Sd-fine Pvt. Ltd. Mumbai, India.

Collection and identification of plant materials

The leaves of Tecomaria capensis (Thunb.) Spach. were collected from Guntur district, AP and it was authenticated by professor Dr. S. M. Khasim, Department of Botany and Microbiology, Acharya Nagarjuna University, Guntur. The specimen (No: ANU/00129/2009/AP) was deposited in the Department of Botany and microbiology for future reference.

Determination of various physicochemical constants

The determination of several physico chemical constants were done as per the protocol given in the practical pharmacognosy Mr. S. B. Gokhale, Dr. C. K. Kokate Nirali Prakashan, 07-Aug-2008 [12].

Preparation of extracts

The techniques commonly used in the field of photochemistry were extraction, isolation and structural elucidation of natural products, as well as chromatographic techniques. The solvent extraction of any botanical materials may yield very less quantity of volatile oils and a large yield of non-volatile components like resins, pigments, waxes and fatty acids.

Successive solvent extraction

This extract was prepared by using soxhlet apparatus. About 150 gm of dried flower powder was taken in a muslin cloth bag. The purified ethanol was passed through the tube where the powder bag was kept. The solvent was passed through siphon tube so that it reaches the round bottom flask in which porcelain chips were provided. The vapours containing the constituents pass through the condenser and reach the tube containing powder bag and the process was repeated. This was continued for 24 hours. Then the round bottom flask containing extract was transferred to a beaker and was allowed to evaporate in a water bath.

Preliminary phytochemical identification

The following chemical tests were performed to identify the phytochemical constituents present in pet.ether, n.hexane, chloroform, ethyl acetate, ethanol and aqueous extracts of Tecomaria capensis.

Isolation and purification of active compounds

Analytical TLC: Analytical TLC was carried out on preparative TLC plates (5 × 5 cm with 0.2 mm thickness, silica gel GF254, Merck, Darmstadt, Germany) cut from the commercially available sheets. An aliquot of a sample solution of crude extract was spotted onto the silica gel plate and allowed to dry for a few minutes. Afterwards, the chromatoplate was developed with toluene and ethyl acetate in ratio 7:3, fractions were isolated and similar fraction were clubbed as mobile phase in a previously saturated glass chamber with eluting solvents for some time at room temperature. The developed plate was dried under normal air and the spots were visualised by spraying with a solution of 0.5%w/v ferric chloride and dried under oven. The (retention factor) values of isolated compounds and standard were calculated and compared.

Preparative TLC for purification: A streak of crude extract was applied manually on a preparative TLC glass plate (20 cm × 20 cm; 1500 μm thickness) with inorganic fluorescent indicator binder (Analtech, Sigma-Aldrich, Steinheim, Germany). After air drying, the plate was developed, using the same mobile phase as used in the analytical TLC, in a pre-saturated glass chamber. In each experiment, two plates were used in parallel. One of the plates from each set of experiment was sprayed with as described above, and the bands were scraped off carefully from the plate. The scratched sample was dissolved in HPLC grade methanol and centrifuged at 12000 rpm for 15 min in order to remove silica. The supernatant was collected, filtered from 0.22 μm filter, and dried under reduced pressure. Further, all the dried samples were passed under nitrogen gas for 5 min and then dissolved in methanol for further characterization and quantitative HPLC analysis. The entire purification process was carried out under dark or dim light conditions.

Column chromatography: 10 grams of extract was defatted using n-hexane for 6 hours for the removal of fatty materials then the material was dried and dissolved in ethyl-acetate (100 ml) about 500 grams of silica G* was activated and column chromatography was runned from the mixture of toluene and ethyl acetate in ratio (7:3 v/v), fractions were isolated and similar fraction were clubbed.

Characterization of purified compound: It is very helpful record which would give information about functional group present in the organic compounds. Mechanism of bond stretching and bending is happened when electromagnetic radiation ranging from 500 cm-1 to 4000 cm-1 passed through sample. Instrument used was ABD BOWMEN Spectrometer. ESI mass spectra was acquired from isolated compound and characterized by using JOEL Gcmate Mass spectrometer. Proton nuclear magnetic resonance spectra were acquired using 400 MHZ NMR spectrometer employing TMS as an internal standard and deuterated methanol was used as solvent.

Antifungal activity

The Antifungal activity of the isolated β-lapachone from ethyl acetate extract was tested against Aspergillus niger and Candida albicans. The antifungal sensitivity pattern for the isolates was studied by the disc diffusion method. Potato dextrose agar media was made and the plates were swabbed with the cultures of respective fungi grown in nutrient broth. Sterile discs of 6 mm diameter were impregnated with 25 μg/ml, 50 μg/ml, 100 μg/ml each separately. Blank disc impregnated with DMSO was used as negative control and discs of Fluconazole (30 μg/ml) as positive control. The plates were then incubated at 37°C for 24 hrs. The antifungal activity was assessed by measuring the zone of inhibition. The relative antifungal activity of the extract was calculated by comparing its zone of inhibition with the standard drugs. Inhibition was recorded by measuring the diameter of inhibition zone at the end of 24 h [13].

Results and Discussion

Complete extraction of β-Lapachone was achieved by successive solvent extraction with ethyl acetate. Preliminary phytochemical study reveals that the ethyl acetate extract contain alkaloids, flavonoids, cardiac glycosides, coumarin glycosides, proteins, tannins, steroids, inulin, terpenoids, volatile oil and mucilage showed in Tables 1 and 2. Several mobile phase combinations were tried and mixture of toluene and ethyl acetate in ratio 7:3 was found optimum for isolation of β-Lapachone. The Rf values of sample compound was found as 0.3625 cm. TLC profile of compound was represented in Figures 1 and 2. Isolation of β-Lapachone from the extract was achieved by preparative thin layer chromatography. Characterization of isolated compound was done by studying FT-IR Vmax (KBr) cm-1: 1730, 1655, 1375, 1222.5; Its FT- IR values showed the following functional groups # 1730(C=O), 1655(C=C), 1375(CH3), 1222.5(C-O). H1NMR1H NMR (δ ppm): 7.3280-7.8891(4H, m), 2.5070(2H, s), 1.9955(2H, s), 1.399(6H, s)Its 1H NMR displayed a signal of 4H multiplet 7.3280-7.8891 referred to aromatic ring, 2H singlet 2.5070 and 1.9955 referred to two methylene group, 3H singlet 1.399 referred for two methyl groups. 13C NMR from the 13C NMR showed 15 carbons, 137.92, 137.40, 136.71, 136.04, 133.89, 127.49 referred to benzene ring, 164.33, 112.21 referred to ethylene group, 181.11, 177.20 referred to carbonyl group, 78.80 referred to fully substituted C, 35.14, 15.94 referred to CH2, 27.74, 27.74 referred to CH3. Mass spectral data shows molecular ion peak m/z: 242.09. H1 NMR and 13C NMR spectra show different kinds of protons in the compound which was seen in the spectra and its assignment resembles the complete structure of β-lapachone shown in Figure 2. Zone of inhibition of β-lapachone against the selected fungi are seen in Table 3. The antifungal activities of the different extracts of the isolated compound β-lapachone at different concentrations were determined. The two different concentrations (25, 50 and 100 μg/ml and in DMSO) exhibited antifungal activity against Candida albicans and Aspergillus niger. The solvent doesn’t interfere in Anti-fungal activity. The positive control Flucanzole showed significant activity against both the fungi Candidaalbicans was 19 ± 0.816 mm and for Aspergillus niger it showed inhibition zone of 18 ± 0.481 mm. At 25 μg/ml β-lapachone showed zone of inhibition against Candida albicans was 15 ± 0.821 mm, 16 ± 0.471 mm (50 μg/ml) and 100 μg/ml with the zone of 18 ± 0.512 mm respectively. For Aspergillus niger it showed zone of inhibition of 16 ± 0.471 mm and 100 μg/ml with the zone of 18 ± 0.512 mm. The isolated β-lapachone showed dose–dependent and significant activity against all two fungi. The antifungal results are shown in Table 3.

medicinal-aromatic-plants-Analytical-TLC

Figure 1: Analytical TLC of isolation of β-lapachone.

medicinal-aromatic-plants-Chemical-structure

Figure 2: Chemical structure of β -Lapachone structure.

S No Physico-chemical constant Values
1 Moisture Content (Loss on Drying) 1%
2 Foreign Matter 2%
3 Alcohol Soluble Extraction 0.25 gm
4 Water Soluble Extraction 0.36 gm
5 Ether Soluble Extraction 0.04 gm
6 Total Ash Value 0.93
7 Acid Insoluble Ash Value 0.01
8 Sulphated Ash Value 0.06
9 Water Soluble Ash Value 0.05

Table 1: Determination of Various Physico Chemical Constant.

Phyto constituents Pet. Ether n-hexane Chloroform Ethylacetate Ethanol Water
Alkaloids -- -- -- -- ++ --
Flavinoids -- -- ++ ++ ++ ++
Cardiac Glycosides ++ ++ ++ ++ ++ --
Saponin Glycosides ++ ++ ++ ++ -- --
Coumarin Glycosides -- -- -- ++ ++ --
Tannins -- -- -- -- ++ --
Steroids and Terpinoids -- ++ ++ ++ ++ --
Carbohydrates -- -- -- ++ -- --
Protein -- -- -- ++ ++ --
Inulin -- -- -- -- ++ ++
Volatile oil ++ ++ ++ ++ ++ --
Waxes -- -- -- -- -- --
Mucilage -- -- -- -- ++ ++

Table 2: Results of Preliminary Phytochemical Identification.

S No Sample Treatment(µg/ml) Name of the fungi
Candida albicans Aspergillusniger
1 β-lapachone
25
50
100
  15 ± 0.821mm
*16 ± 0.471mm
*18 ± 0.512mm
  14 ± 0.821mm
*16 ± 0.491mm
*16 ± 0.372mm
2 Flucanzole(positive control) (30) *19 ± 0.816mm *18 ± 0.481mm
3 DMSO(negative control) (25 µl) NZI NZI
SD ± mean; *P Value>0.001 is considered as significant; NZI – No zone of inhibition

Table 3: Zone of inhibition of β –Lapachone against the different fungi.

Conclusion

Isolation, characterization of β –Lapachone was achieved successfully which will be helpful for the standardization of active constituent in herbal formulations. The Isolated β –Lapachone has significant anti-fungal action and showed comparable action with the standard Flucanzole. β –Lapachone showed significant activity against Aspergillus niger and Candida albicans so it can be used as narrow spectrum of anti-fungal agent.

Conflicts of Interest

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgements

The authors would like to thank to Dr. L. Rathaiah, Honorable Chairman, Vignan group of institutions, Vadlamudi, Guntur for providing the necessary facilities to carry out this research work.

References

  1. Huang L, Pardee AB (1999) beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells.Mol Med 5: 711-720.
  2. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JW (1984) beta-Lapachone: synthesis of derivatives and activities in tumor models.J Med Chem 27: 990-994.
  3. Don MJ, Chang YH, Chen KK, Ho LK, Chau YP (2001) Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the beta-lapachone-induced apoptosis of human prostate cancer cells.MolPharmacol 59: 784-794.
  4. Goijman SG, Stoppani AO (1985) Effects of beta-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosomacruzi.Arch BiochemBiophys 240: 273-280.
  5. Guiraud P, Steiman R, Campos-Takaki GM, Seigle-Murandi F, Simeon de Buochberg M (1994) Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone.Planta Med 60: 373-374.
  6. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JW (1984) beta-Lapachone: synthesis of derivatives and activities in tumor models.J Med Chem 27: 990-994.
  7. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, et al. (1995) Beta-lapachone-mediated apoptosis in human promyelocyticleukemia (HL-60) and human prostate cancer cells: a p53-independent response.Cancer Res 55: 3706-3711.
  8. Li CJ, Wang C, Pardee AB (1995) Induction of apoptosis by beta-lapachone in human prostate cancer cells.Cancer Res 55: 3712-3715.
  9. Weller M, Winter S, Schmidt C, Esser P, Fontana A, et al. (1997) Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.Int J Cancer 73: 707-714.
  10. Lai CC, Liu TJ, Ho LK, Don MJ, Chau YP (1998) beta-Lapachone induced cell death in human hepatoma (HepA2) cells.HistolHistopathol 13: 89-97.
  11. Huang L, Pardee AB (1999) beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells.Mol Med 5: 711-720.
  12. Woo HJ, Park KY, Rhu CH, Lee WH, Choi BT, et al. (2006) Beta-lapachone, a quinone isolated from Tabebuiaavellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase.J Med Food 9: 161-168.
  13. Wuerzberger SM, Pink JJ, Planchon SM, Byers KL, Bornmann WG, et al. (1998) Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.Cancer Res 58: 1876-1885.
  14. Li CJ, Li YZ, Pinto AV, Pardee AB (1999) Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints.ProcNatlAcadSci U S A 96: 13369-13374.
  15. Li Y, Li CJ, Yu D, Pardee AB (2000) Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells.Mol Med 6: 1008-1015.
  16. Li YZ, Li CJ, Pinto AV, Pardee AB (1999) Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells.Mol Med 5: 232-239.
  17. Salas C, Tapia RA, Ciudad K, Armstrong V, Orellana M, et al. (2008) Trypanosomacruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.Bioorg Med Chem 16: 668-674.
  18. Pereira EM, Machado TB, Leal IC, Jesus DM, Damaso CR, et al. (2006) Tabebuiaavellanedaenaphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis Ann ClinMicrobiolAntimicrob 5: 5.
  19. Blanco E, Bey EA, Dong Y, Weinberg BD, Sutton DM, et al. (2007) Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.J Control Release 122: 365-374.
  20. Guiraud P, Steiman R, Campos-Takaki GM, Seigle-Murandi F, Simeon de Buochberg M (1994) Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone.Planta Med 60: 373-374.
Citation: Karthikeyan R, Sai Koushik O, Kumar PV (2016) Isolation, Characterisation and Antifungal Activity of β-Lapachone from Tecomaria capensis (Thunb.) Spach Leaves Med Aromat Plants 5:239.

Copyright: © 2016 Karthikeyan R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top